Literature DB >> 2985802

Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus.

S Makino, N Fujioka, K Fujiwara.   

Abstract

The intracellular defective RNAs generated during high-multiplicity serial passages of mouse hepatitis virus JHM strain on DBT cells were examined. Seven novel species of single-stranded polyadenylic acid-containing defective RNAs were identified from passages 3 through 22. The largest of these RNAs, DIssA (molecular weight [mw], 5.2 X 10(6)), is identical to the genomic RNA packaged in the defective interfering particles produced from these cells. Other RNA species, DIssB1 (mw, 1.9 X 10(6) to 1.6 X 10(6)), DIssB2 (mw, 1.6 X 10(6)), DIssC (mw, 2.8 X 10(6)) DIssD (mw, 0.82 X 10(6)), DIssE (mw, 0.78 X 10(6)), and DIssF (mw, 1.3 X 10(6)) were detected at different passage levels. RNase T1-resistant oligonucleotide fingerprinting demonstrated that all these RNAs were related and had multiple deletions of the genomic sequences. They contained different subsets of the genomic sequences from those of the standard intracellular mRNAs of nondefective mouse hepatitis virus JHM strain. Thus these novel intracellular viral RNAs were identified as defective interfering RNAs of mouse hepatitis virus JHM strain. The synthesis of six of the seven normal mRNA species specific to mouse hepatitis virus JHM strain was completely inhibited when cells were infected with viruses of late-passage levels. However, the synthesis of RNA7 and its product, viral nucleoprotein, was not significantly altered in late passages. The possible mechanism for the generation of defective interfering RNAs was discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985802      PMCID: PMC254801     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Phosphoproteins of murine hepatitis viruses.

Authors:  S A Stohlman; M M Lai
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Oligonucleotide mapping studies of standard and defective Sindbis virus RNA.

Authors:  D Dohner; S Monroe; B Weiss; S Schlesinger
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Extraction of nucleic acids from agarose gels.

Authors:  J Langridge; P Langridge; P L Bergquist
Journal:  Anal Biochem       Date:  1980-04       Impact factor: 3.365

5.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

6.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid.

Authors:  L S Sturman; K V Holmes; J Behnke
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Defective interfering passages of Sindbis virus: nature of the defective virion RNA.

Authors:  S I Kennedy; C J Bruton; B Weiss; S Schlesinger
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

9.  Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells.

Authors:  T Kumanishi
Journal:  Jpn J Exp Med       Date:  1967-10

10.  Coronavirus JHM: cell-free synthesis of structural protein p60.

Authors:  S G Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more
  54 in total

1.  Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome.

Authors:  B Hsue; T Hartshorne; P S Masters
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.

Authors:  T M Gallagher; S E Parker; M J Buchmeier
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 6.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

7.  A bulged stem-loop structure in the 3' untranslated region of the genome of the coronavirus mouse hepatitis virus is essential for replication.

Authors:  B Hsue; P S Masters
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Replication of murine coronavirus defective interfering RNA from negative-strand transcripts.

Authors:  M Joo; S Banerjee; S Makino
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis.

Authors:  X Zhang; C L Liao; M M Lai
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.